Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment
Open Access
- 6 July 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7447
Abstract
Nonalcoholic steatohepatitis (NASH) and alcoholic hepatitis (AH) affect a large part of the general population worldwide. Dysregulation of lipid metabolism and alcohol toxicity drive disease progression by the activation of hepatic stellate cells and the capillarization of liver sinusoidal endothelial cells. Collagen deposition, along with sinusoidal remodeling, alters sinusoid structure, resulting in hepatic inflammation, portal hypertension, liver failure, and other complications. Efforts were made to develop treatments for NASH and AH. However, the success of such treatments is limited and unpredictable. We report a strategy for NASH and AH treatment involving the induction of integrin αvβ3-mediated cell apoptosis using a rationally designed protein (ProAgio). Integrin αvβ3 is highly expressed in activated hepatic stellate cells (αHSCs), the angiogenic endothelium, and capillarized liver sinusoidal endothelial cells (caLSECs). ProAgio induces the apoptosis of these disease-driving cells, therefore decreasing collagen fibril, reversing sinusoid remodeling, and reducing immune cell infiltration. The reversal of sinusoid remodeling reduces the expression of leukocyte adhesion molecules on LSECs, thus decreasing leukocyte infiltration/activation in the diseased liver. Our studies present a novel and effective approach for NASH and AH treatment.Keywords
Funding Information
- National Institute of Health (CA175112, CA118113, CA178730, CA217482)
- Georgia Cancer Coalition (CA175112, CA118113, CA178730, CA217482)
- NIDDK R01 DK126080-01A1 (CA175112, CA118113, CA178730, CA217482)
- UT2AA028659-01 (CA175112, CA118113, CA178730, CA217482)
- MBD fellowship, GSU (CA175112, CA118113, CA178730, CA217482)
- Center for Diagnosis and Therapeutics fellowship, GSU (CA175112, CA118113, CA178730, CA217482)
This publication has 62 references indexed in Scilit:
- Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive HepatopathyHepatology Communications, 2021
- Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune‐mediated hepatitisHepatology, 2015
- Liver sinusoidal endothelial cells in hepatic fibrosisHepatology, 2014
- Hepatic inflammation and fibrosis: Functional links and key pathwaysHepatology, 2014
- Hepatic Stellate Cells and Liver Fibrosis2013
- Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrin αvβ3 expression with SPECT in ratHepatology, 2011
- Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis #Hepatology, 2009
- Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescenceHepatology, 2008
- Angiogenesis in chronic inflammatory liver diseaseHepatology, 2004
- Endothelial activation and circulating vascular adhesion molecules in alcoholic liver diseaseHepatology, 1994